Kawabata A

No ORCID on file · 10 papers in corpus · active 2017-2026

Study types

  • other 2
  • preprint 1

Condition tags

  • endometriosis 3
  • adenomyosis 1
2026
·doi:10.21203/rs.3.rs-9201156/v1

Abstract Objectives To evaluate whether pretreatment magnetic resonance imaging (MRI) parameters can predict response to hormonal therapy in patients with adenomyosis. Methods This retrospective study included 78 patients with MRI-diag…

2026
Abdominal radiology (New York) ·doi:10.1007/s00261-026-05592-0

OBJECTIVES: To evaluate whether pretreatment magnetic resonance imaging (MRI) parameters can predict short-term clinical response to dienogest (DNG) in patients with adenomyosis. METHODS: This retrospective study included 78 patients with …

preprint 2026
·doi:10.64898/2026.05.29.728698

Abstract Purpose Ovarian clear cell carcinoma (OCCC) is strongly associated with endometriosis and shows geographic variation in incidence. We investigated whether OCCC and adjacent endometriosis exhibit distinct transcriptional states and …

2022
Current issues in molecular biology ·doi:10.3390/cimb44040108

Epithelial ovarian cancer is classified into four major histological subtypes: serous, clear cell, endometrioid and mucinous. Ovarian clear cell carcinoma (OCCC) responds poorly to conventional chemotherapies and shows poor prognosis. Thus,…

2021
Cells ·doi:10.3390/cells10081881

A neuroimmune crosstalk is involved in somatic and visceral pathological pain including inflammatory and neuropathic components. Apart from microglia essential for spinal and supraspinal pain processing, the interaction of bone marrow-deriv…

2021
PloS one ·doi:10.1371/journal.pone.0261473

Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting adverse reaction in cancer patients treated with several cytotoxic anticancer agents including paclitaxel. Duloxetine, an antidepressant known as a serotonin-noradrenalin …

2020
International journal of clinical oncology ·doi:10.1007/s10147-020-01625-w

Ovarian clear cell carcinoma (OCCC), with unique clinical and molecular characteristics compared with other histological types of epithelial ovarian cancer (EOC), behaves like a distinct entity and has a poorer prognosis than other EOC type…

other 2018
Oncotarget ·doi:10.18632/oncotarget.24555

Ovarian clear cell carcinoma (OCCC) exhibits distinct phenotypes, such as resistance to chemotherapy, poor prognosis and an association with endometriosis. Biomarkers and imaging techniques currently in use are not sufficient for reliable d…

2017
Gynecology and Minimally Invasive Therapy ·doi:10.1016/j.gmit.2016.12.001

Study objectiveTo describe Higuchi's transverse incision and a modification of this method for reduced port surgery (RPS).DesignDescriptive study.SettingUniversity hospital.PatientsThose with ovarian cyst and uterine myoma.InterventionA pla…

other 2017
Gynecologic oncology ·doi:10.1016/j.ygyno.2017.06.027

OBJECTIVE: Ovarian clear cell carcinoma (OCCC) frequently presents at an early stage. In stage I OCCC, the prognosis differs according to substage. In particular, predictive biomarkers and new treatment strategies are needed for stage IC2/I…